The bill raises penalties to deter and punish large-scale healthcare fraud—likely reducing fraud and protecting patients and payers—but at the cost of higher incarceration, enforcement, and compliance expenses and an increased risk of harsher, uneven, or overbroad punishment for providers and other actors.
Patients and the public (especially people with chronic conditions) are likely to face fewer large-scale healthcare fraud schemes because substantially higher maximum penalties strengthen deterrence against sophisticated fraud.
Hospitals, insurers, and public payers may avoid large-scale losses and save public healthcare dollars if stronger penalties deter fraudulent billing and false statements.
Prosecutors may be better able to pursue major fraudsters, seek tougher sentences, recover assets, and secure plea agreements against large-scale offenders.
Taxpayers will likely face higher incarceration and prison-system costs because maximum prison terms for many healthcare fraud offenses are substantially increased.
Hospitals, healthcare workers, and providers face much greater criminal and financial exposure (longer prison terms and larger fines), increasing risk to institutions and staff.
Higher penalties could drive increased defensive practices, greater compliance and administrative costs for providers, and a chilling effect on legitimate care or information-sharing.
Based on analysis of 4 sections of legislative text.
Raises criminal penalties and some fines for health care fraud and related federal-program offenses and directs the Sentencing Commission to review sentencing guidelines for those crimes.
Introduced February 13, 2026 by Aaron Bean · Last progress February 13, 2026
Increases criminal penalties for health care fraud and certain crimes affecting federal health care programs, raises maximum prison terms and some monetary penalties, and directs the U.S. Sentencing Commission to review and, if appropriate, revise sentencing guidelines for those offenses. Changes apply prospectively to offenses committed on or after the law’s enactment date and require the Commission to consider specific aggravating and mitigating factors when updating guideline ranges.